The value of mental science: we publish what matters.
Malhi GS. et al, (2025), Br J Psychiatry, 1 - 5
Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics
Roope LSJ. et al, (2025), Contemporary Clinical Trials Communications, 45
Patient and Physician Exposure to Artificial Intelligence Hype.
Monteith S. et al, (2025), Pharmacopsychiatry
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial.
Kerr-Gaffney J. et al, (2025), Health Technol Assess, 29, 1 - 118
Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.
McAllister-Williams H. et al, (2025), Health Technol Assess, 29, 1 - 216
Effect of lithium on circadian activity level and flexibility in patients with bipolar disorder: results from the Oxford Lithium Trial.
Xu N. et al, (2025), EBioMedicine, 115
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK.
Cleare AJ. et al, (2025), Lancet Psychiatry, 12, 276 - 288
Neural signatures of risk-taking adaptions across health, bipolar disorder, and lithium treatment.
Scholl J. et al, (2025), Mol Psychiatry
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study).
McAllister-Williams RH. et al, (2025), J Psychopharmacol
Personality disorders, violence and antisocial behaviour: updated systematic review and meta-regression analysis.
Chow RTS. et al, (2024), Br J Psychiatry, 1 - 11
Artificial intelligence and cybercrime: implications for individuals and the healthcare sector.
Monteith S. et al, (2024), Br J Psychiatry, 1 - 3
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.
Leavy OC. et al, (2024), ERJ Open Res, 10
Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.
Taquet M. et al, (2024), Lancet Psychiatry, 11, 696 - 708
Implications of Online Self-Diagnosis in Psychiatry.
Monteith S. et al, (2024), Pharmacopsychiatry, 57, 45 - 52
Co-design of 'Ways of Being', a web-based experience to optimise online arts and culture for mental health in young people.
Syed Sheriff RJ. et al, (2024), BJPsych Bull, 1 - 8
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Elneima O. et al, (2024), International Journal of Epidemiology, 53
Violence in schizophrenia: triangulating the evidence on perpetration risk.
Whiting D. et al, (2024), World Psychiatry, 23, 158 - 160